"Opren scandal".
D000329:Advertising; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D035843:Biomedical Research; D004345:Drug Industry; D004994:Ethics, Pharmacy; D006801:Humans; D011422:Propionates / Q000009:adverse effects*; D011639:Public Opinion; D006113:United Kingdom
D000893:Anti-Inflammatory Agents; D011422:Propionates; C011677:benoxaprofen